Tag:
Pervasis Therapeutics
Latest Headlines
Latest Headlines
Shire picks up Pervasis in potential $200M deal
Shire didn't disclose the exact deal terms in its announcement today, but the deal could be worth up to $200 million.
Regenerative medicine could be $20B market in 15 years
The regenerative medicine field could experience explosive growth, from $1.6 billion to $15 to $20 billion over the next 15 years, according to Scientia Advisors' new market review. The short-term
